Naloxone Guidelines Act of 2018

Bill: 115-hr-5926
Sponsor: full_name: Rep. Keating, William R. [D-MA-9]
Introduced: 2018-05-23
Policy area: Health
Subjects: Drug therapy

Drug, alcohol, tobacco use

Health promotion and preventive care

Health technology, devices, supplies

Prescription drugs
Latest action: action_date: 2018-05-23
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2018-05-23
action_desc: Introduced in House
text: <p><b>Naloxone Guidelines Act of 2018</b></p> <p>This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone). </p> <p>The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including: </p> <ul> <li> co-prescription with an opioid;</li> <li>safe dosages;</li> <li> prescription for non-patients; and</li> <li>standing orders (i.e., orders that allow dispensing without a prescription).</li></ul>

tv_txt: I 115th CONGRESS 2d Session H. R. 5926 IN THE HOUSE OF REPRESENTATIVES May 23, 2018 Mr. Keating (for himself and Mr. Rothfus ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.

1. Short title This Act may be cited as the Naloxone Guidelines Act of 2018 . 2. Guidelines for prescribing naloxone (a) In general Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidelines for prescribing an opioid overdose reversal drug. (b) Contents In issuing guidelines under subsection (a), the Secretary shall address the following: (1) Co-prescribing an opioid overdose reversal drug in conjunction with any prescribed opioid. (2) Dosage safety. (3) Prescribing an opioid overdose reversal drug to an individual other than a patient. (4) Standing orders. (5) Other distribution, education, and safety measures as determined necessary.